News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,108 Results
Type
Article (51057)
Company Profile (319)
Press Release (642732)
Section
Business (198782)
Career Advice (2638)
Deals (36779)
Drug Delivery (123)
Drug Development (81816)
Employer Resources (161)
FDA (17245)
Job Trends (15073)
News (344322)
Policy (34084)
Tag
Academia (2634)
Alliances (51562)
Alzheimer's disease (1407)
Approvals (17197)
Artificial intelligence (235)
Bankruptcy (345)
Best Places to Work (11408)
Biotechnology (190)
Breast cancer (234)
Cancer (1791)
Cardiovascular disease (146)
Career advice (2202)
CAR-T (138)
Cell therapy (389)
Clinical research (65684)
Collaboration (702)
Compensation (380)
COVID-19 (2736)
C-suite (166)
Data (1633)
Diabetes (227)
Diagnostics (6469)
Earnings (76650)
Employer resources (146)
Events (106315)
Executive appointments (582)
FDA (18184)
Funding (610)
Gene therapy (276)
GLP-1 (754)
Government (4138)
Healthcare (18073)
Infectious disease (2859)
Inflammatory bowel disease (127)
Interviews (481)
IPO (16320)
Job creations (4127)
Job search strategy (1848)
Layoffs (498)
Legal (8378)
Lung cancer (268)
Manufacturing (263)
Medical device (13839)
Medtech (13844)
Mergers & acquisitions (20867)
Metabolic disorders (625)
Neuroscience (1857)
NextGen: Class of 2025 (6425)
Non-profit (3853)
Northern California (2104)
Obesity (354)
Opinion (251)
Patents (174)
People (57705)
Phase I (20388)
Phase II (28644)
Phase III (21981)
Pipeline (739)
Postmarket research (2655)
Preclinical (8520)
Radiopharmaceuticals (250)
Rare diseases (353)
Real estate (6137)
Regulatory (23431)
Research institute (2407)
Resumes & cover letters (432)
Southern California (1787)
Startups (3790)
United States (18701)
Vaccines (709)
Weight loss (269)
Date
Today (10)
Last 7 days (637)
Last 30 days (2661)
Last 365 days (35386)
2025 (4670)
2024 (36116)
2023 (40654)
2022 (51742)
2021 (55935)
2020 (53829)
2019 (45809)
2018 (34784)
2017 (34098)
2016 (33668)
2015 (38521)
2014 (31568)
2013 (26586)
2012 (28751)
2011 (29242)
2010 (27070)
Location
Africa (858)
Arizona (201)
Asia (42951)
Australia (6927)
California (4798)
Canada (1666)
China (411)
Colorado (220)
Connecticut (246)
Europe (94574)
Florida (695)
Georgia (168)
Illinois (459)
Indiana (265)
Maryland (781)
Massachusetts (3694)
Michigan (211)
Minnesota (331)
New Jersey (1378)
New York (1333)
North Carolina (890)
Northern California (2104)
Ohio (169)
Pennsylvania (1075)
South America (1252)
Southern California (1787)
Texas (709)
Utah (142)
Washington State (479)
694,108 Results for "avadel pharma flamel technologies s a acquired avadel".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ASL Strategic Value Fund Letter to Avadel Pharmaceuticals (AVDL: NASDAQ) Board of Directors
February 10, 2025
·
4 min read
Press Releases
Avadel Pharmaceuticals Appoints Sev Melkonian as Vice President of Patient Services, Distribution, and Reimbursement
January 22, 2025
·
2 min read
Press Releases
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - February 20, 2025
February 21, 2025
·
1 min read
Avadel Pharmaceuticals to Present at Upcoming June 2024 Investor Conferences
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced that members of management will participate in the following upcoming investor conferences.
May 30, 2024
·
1 min read
Press Releases
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 13, 2024
·
1 min read
Press Releases
Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8
January 3, 2025
·
1 min read
Avadel Pharmaceuticals to Join Russell 3000® Index - June 27, 2024
Avadel Pharmaceuticals plc announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024, according to a preliminary list of additions posted Friday, May 24, 2024.
June 27, 2024
·
3 min read
Press Releases
Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch
January 9, 2025
·
12 min read
Business
Avadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of Directors
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced the appointment of Naseem Amin, M.D. to its board of directors, effective May 17, 2024.
May 21, 2024
·
4 min read
Press Releases
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - January 6, 2025
January 7, 2025
·
1 min read
1 of 69,411
Next
